Funding Rounds
Aptadir Therapeutics

Aptadir Therapeutics Pre-Seed Round, September 2024

Aptadir Therapeutics

RNA inhibitor-based therapeutics developer for treating intractable cancers and genetic conditions.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Pre Seed

Raised Amount: $1.60M

Raised Date: 2024-09-24

Investors